0001640455-18-000015.txt : 20180205 0001640455-18-000015.hdr.sgml : 20180205 20180205180716 ACCESSION NUMBER: 0001640455-18-000015 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180201 FILED AS OF DATE: 20180205 DATE AS OF CHANGE: 20180205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Trehu Elizabeth CENTRAL INDEX KEY: 0001693456 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37998 FILM NUMBER: 18575554 MAIL ADDRESS: STREET 1: C/O JOUNCE THERAPEUTICS, INC. STREET 2: 1030 MASSACHUSETTS AVENUE CITY: CAMBRIDGE STATE: MA ZIP: 02138 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Jounce Therapeutics, Inc. CENTRAL INDEX KEY: 0001640455 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 454870634 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 780 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-259-3840 MAIL ADDRESS: STREET 1: 780 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 wf-form4_151787202263888.xml FORM 4 X0306 4 2018-02-01 0 0001640455 Jounce Therapeutics, Inc. JNCE 0001693456 Trehu Elizabeth C/O JOUNCE THERAPEUTICS, INC. 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 0 1 0 0 Chief Medical Officer Stock Option (Right to Buy) 23.98 2018-02-01 4 A 0 70500 0 A 2028-02-01 Common Stock 70500.0 70500 D The option will vest quarterly in 16 equal installments following January 1, 2018. /s/ Anna L. Barry, Attorney-in-Fact 2018-02-05